在囊性纤维化中,先天性免疫衰竭的临床含义
Rikke Møller1,2, Bibi Uhre Nielsen1,2, Elio Rossi3,4
1Cystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
ERJ open research
|August 28, 2024
概括
在患有囊性纤维化 (pwCF) 的人群中,先天性免疫反应不能预测肺功能. 慢性感染可能导致pwCF的免疫衰竭.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 微生物学 微生物学
背景情况:
- 患有囊性纤维化 (pwCF) 的人的肺病进展是可变的.
- 免疫学因素可能会解释这种变化.
- 在pwCF中,先天性免疫和肺功能之间的关系尚未得到充分理解.
研究的目的:
- 调查pwCF中先天性免疫反应和肺功能之间的关联.
- 用TruCulture免疫功能测定来探索潜在的联系.
主要方法:
- 分别对52个和24个pwCF进行横截面和纵向研究.
- 通过TruCulture对全血中未刺激和刺激的细胞因子释放的分析.
- 使用托比特回归和斯皮尔曼相关的统计分析.
主要成果:
- 在pwCF中,与健康个体相比,减少了TLR3,TLR4和TLR7/8刺激的干扰素-γ和IL-12p40释放.
- 总体细胞因子释放和肺功能之间的相关性有限.
- 抗生素治疗改变了细胞因子的释放,但治疗前的水平无法预测肺功能变化.
结论:
- 刺激性细胞因子释放没有预测肺功能水平或pwCF的变化.
- 数据表明,慢性细菌感染后pwCF的先天免疫反应疲.
相关概念视频
Cystic Fibrosis: Pathogenesis
198
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
198
Cystic Fibrosis: Management
148
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
148
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Factors Affecting the Risk of Infection
11.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Immunodeficiency Diseases
926
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
926
Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126


